Business Description
Founded in 2006 and headquartered in Huntsville, Alabama, Serina Therapeutics is a medical research company focused on developing new treatments for brain and nervous system conditions, including Parkinson's disease and chronic pain. The company's work centers on its proprietary POZ platform, which is used to improve how drugs are delivered in the body, reducing unwanted immune responses while enhancing effectiveness. Serina has several programs at various stages of development, ranging from early laboratory research to completed early-phase human trials.